Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Biotechnology

Healthcare
$18.31 +0.58%

+$0.10 today

Market cap
$980.14M
Beta
0.00
52W Low $14.85High $23.00

Volume 0.68M

Average 0.41M

SPTX Operating Income

Profit from core operations after operating expenses, before interest and taxes.

No reported Operating Income figures are available to summarize.

Operating Income history

Currency unavailable · from the income statement

No Operating Income data reported for this period type.

Operating Income vs competitors

How SPTX compares with its peers on the latest reported figures

SPTX Competitors
Operating Income for SPTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
LBRXLB Pharmaceuticals Inc Common StockLTM Mar 2026-$46.86M USD———
GHRSGH Research PLCLTM Mar 2026-$66.69M USD-29.4%——
CTNMContineum Therapeutics, Inc. Class A Common StockLTM Mar 2026-$66.85M USD-256.5%——
RAPPRapport Therapeutics, Inc. Common StockLTM Mar 2026-$122.21M USD-31.3%—611.0%
VNDAVanda Pharmaceuticals Inc.LTM Mar 2026-$160.36M USD-111.1%—73.6%
MPLTMapLight Therapeutics, Inc.LTM Mar 2026-$210.04M USD-140.9%——
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026-$223.08M USD+18.7%——
SPTXSeaport Therapeutics, Inc. Common Stock—— ———
Peer median (excluding SPTX) —-71.2%—342.3%

Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Seaport Therapeutics, Inc. Common Stock

NASDAQ:SPTX

Intrinsic Alpha fair value

Locked

Current Price

$18.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.